Mortality News and Research

RSS

Risk factors among pregnant and postpartum women with COVID-19

Researchers investigated the clinical risk factors associated with adverse outcomes among COVID-19-infected women during pregnancy and postpartum.

30 Aug 2022

Men who have sex with men adopting protective measures against monkeypox virus

The U.S. Centers for Disease Control and Prevention (CDC) recently published the results of a survey specific to monkeypox virus (MPV) infection associated with the American Men's Internet Survey (AMIS) in the Morbidity and Mortality Weekly Report (MMWR).

29 Aug 2022

Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox

A study conducted by scientists from the US Centers for Disease Control and Prevention (CDC) indicates that reducing one-time sexual partnerships among gay, bisexual, and other men who have sex with men can significantly reduce the transmission of the monkeypox virus.

29 Aug 2022

Monkeypox virus detected on household items

The CDC study describes how the monkeypox virus spreads on household surfaces.

29 Aug 2022

Higher tea intake linked with modestly lower risk of death

A prospective study of half a million tea drinkers in the United Kingdom has shown that higher tea intake was associated with a modestly lowered risk of death.

29 Aug 2022

Researchers discover new therapeutic target for triple-negative breast cancer

Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative.

29 Aug 2022

Access to paid sick leave associated with lower mortality among working age-adults in the U.S.

Access to paid sick leave is linked to a lower rate of mortality among US working age men and women, according to new research in the American Journal of Preventive Medicine, published by Elsevier.

29 Aug 2022

Older people experiencing homelessness more likely to die soon

A quarter of the participants in a long-term study of older people experiencing homelessness in Oakland died within a few years of being enrolled, UC San Francisco researchers found.

29 Aug 2022

Combination of anemia and weak muscles increases the risk of death in older people

A study by researchers at the Federal University of São Carlos in Brazil and University College London in the United Kingdom shows that a combination of anemia and weak muscles in older people heightens the risk of death in ten years by 64% for men and by 117% for women.

29 Aug 2022

Study identifies two potential serological biomarkers of monkeypox infection

In a new study, researchers pursued two monkeypox virus (MPXV) immune targets, A35R and H3L, that could be deployed in a serological assay to identify recent MPXV cases.

29 Aug 2022

Artificial intelligence-based risk score improves personalized care for women with heart attacks

Heart attacks in women are more likely to be fatal than in men. The reasons are differences in age and in comorbidity burden which makes risk assessment in women a challenge.

29 Aug 2022

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Researchers investigated whether early treatment with oral antivirals prevented all-cause mortality in hospitalized patients infected with SARS-CoV-2 new variant of concern Omicron BA.2 subvariant.

29 Aug 2022

Review of the risks and benefits of statins in primary prevention of cardiovascular diseases in adults

A new study reviewed evidence from trials and studies to assess the risks and benefits of using statins to prevent or reduce morbidities or mortalities related to cardiovascular disease (CVD).

29 Aug 2022

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

A large-scale international study led by Mount Sinai has yielded the first risk score that can help predict mortality for patients with atrial fibrillation (AFib) who have undergone a successful transcatheter aortic valve replacement (TAVR) and discharged home.

29 Aug 2022

Association between different physical activities and longevity of elder individuals

Researchers investigated whether different leisure time physical activities (LT-PA) were differentially associated with all-cause mortality and mortality risks from cancer or cardiovascular disorders among elder individuals.

29 Aug 2022

$SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction$

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empagliflozin reduce cardiovascular death or hospitalization for heart failure by 20% in heart failure patients with mildly reduced and preserved ejection fraction.

28 Aug 2022

Increased incidence of hypertensive disorders of pregnancy in young Americans

An age-period-cohort analysis investigates the relationship between the age, birth year, and year of delivery with new onset of hypertensive disorders.

28 Aug 2022

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial infarction, nonfatal stroke or cardiovascular death in patients with ischaemic heart disease, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Target blood pressure of 77 mmHg provides no benefit for comatose cardiac arrest survivors

A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in comatose cardiac arrest survivors compared with a 63 mmHg target, according to late breaking research presented in a Hot Line session today at ESC Congress 2022.

28 Aug 2022

Mortality News and Research

Risk factors among pregnant and postpartum women with COVID-19

Men who have sex with men adopting protective measures against monkeypox virus

Gay, and bisexual men changing sexual behavior to reduce risk of monkeypox

Monkeypox virus detected on household items

Higher tea intake linked with modestly lower risk of death

Researchers discover new therapeutic target for triple-negative breast cancer

Access to paid sick leave associated with lower mortality among working age-adults in the U.S.

Older people experiencing homelessness more likely to die soon

Combination of anemia and weak muscles increases the risk of death in older people

Study identifies two potential serological biomarkers of monkeypox infection

Artificial intelligence-based risk score improves personalized care for women with heart attacks

The clinical and virological outcomes associated with molnupiravir or nirmatrelvir–ritonavir use in hospitalized patients with mild-to-moderate COVID-19

Review of the risks and benefits of statins in primary prevention of cardiovascular diseases in adults

New risk assessment tool predicts mortality for atrial fibrillation patients after completion of TAVR

Association between different physical activities and longevity of elder individuals

SGLT2 inhibitors reduce cardiovascular events among heart failure patients with mildly reduced and preserved ejection fraction

Increased incidence of hypertensive disorders of pregnancy in young Americans

Percutaneous coronary intervention provides no benefit in patients with severe left ventricular dysfunction

Gout medicine fails to improve cardiovascular outcomes in patients with ischemic heart disease

Target blood pressure of 77 mmHg provides no benefit for comatose cardiac arrest survivors

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News